This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on October 27, 2022.
Return to the list of Patented Medicine Litigation page.
Dasatinib
SPRYCEL – Bristol-Myers Squibb Canada Co. (NOC Search)
Patents:
- 2366932: APOTEX
- 2519898: PHARMASCIENCE, TARO PHARMACEUTICALS, APOTEX, TEVA
- 2555291: TARO PHARMACEUTICALS, PHARMASCIENCE, TEVA
APOTEX
- PM(NOC) – A-106-17 (2017 FCA 190) – T-1100-15 (2017 FC 296)
PHARMASCIENCE
- PM(NOC) – T-1369-19
TARO PHARMACEUTICALS
- PM(NOC) – T-1296-19
TEVA
- PM(NOC) – T-1774-18
Return to the Patented Medicine Litigation page.